Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Opticon's catheter shows promise in pilot study:

This article was originally published in Clinica

Executive Summary

Opticon Medical's valved urological catheter for the short-term management of urinary retention following lower urinary tract surgery has shown promising results in a pilot clinical study. The trial, which evaluated the Dublin, Ohio-based company catheter in 42 women, indicated that "a self-controlled valved catheter is feasible, safe and appreciated by patients," said study leader, Dr Rodney Appell of the Cleveland Clinic, Ohio. Dublin, Ohio Opticon plans to meet with the FDA in September to discuss the design of a multi-centre clinical trial of the device in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel